Pipeline

August Bio is currently readying an undisclosed program to advance through the next phase of clinical development. In parallel, August Bio is seeking to expand the pipeline through licensing in more programs that have cleared phase 1 safety testing and have initial clinical efficacy and/or a strong preclinical data package demonstrating activity.